17:04 EDT Rein Therapeutics (RNTX) files to sell 10M shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNTX:
- Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
- Palo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
- Rein Therapeutics Gains Approval for Phase 2 Trial
- Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
- Rein Therapeutics downgraded to Hold from Buy at Brookline
